लोड हो रहा है...
Immunotherapy of advanced renal cell carcinoma: Current and future therapies
Previously a malignancy with few therapeutic options, metastatic renal cell carcinoma (mRCC) treatment is rapidly evolving. Although cytokine therapies (interferon-a, interleukin-2) have been used less frequently over the past decade, recent approval of an immune checkpoint inhibitor, nivolumab, has...
में बचाया:
| में प्रकाशित: | Hum Vaccin Immunother |
|---|---|
| मुख्य लेखकों: | , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Taylor & Francis
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215367/ https://ncbi.nlm.nih.gov/pubmed/27494417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1212794 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|